Tag: IP

Pat-INFORMED – The Gateway to Medicine Patent Information
IFPMA Statement @EB 142: Global strategy and plan of action on public health, innovation and intellectual property
IFPMA 2017 Interview Series: WHO Dr Peter Beyer’s Take on Pat-INFORMED
IFPMA 2017 Interview Series: IFPMA DG Thomas Cueni’s Take on Pat-INFORMED
ICC principles on creating and nurturing innovation ecosystems for high-tech industries
Sustainable innovation
LDCs request for extension of TRIPS implementation
IFPMA 2014 interview series 'What’s an innovation ecosystem from an industry perspective'
IFPMA 2014 interview Series: Andrew Jenner's take on 'Value of innovation'
Technical Briefing: Launch Event of 'Assessing the Value of Biopharmaceutical Innovation in Key Therapy Areas
Assessing the value of biopharmaceutical innovation in key therapy areas in middle-income countries
New study captures the value of new medicines in middle-income countries
Incremental innovation: Adapting to patient needs
Technical Briefing: Making Natural Product Research Work
Open innovation to tackle climate change, part 1
Open innovation to tackle climate change, part 2
Open innovation: what it is and how it is changing business models, part 2
Open innovation: what it is and how it is changing business models, part 1
Open Innovation - Introduction
Open innovation to expand communications
Technology transfer: a collaborative approach to improve global health
IFPMA supports call for extension of TRIPS compliance deadline for least developed countries
25th IFPMA assembly explores theme of “A shared commitment to global health”
WIPO standing committee on the law of patents
Adaptive innovation, intellectual property and public interest

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Code of Practice collaboration Counterfeit Medicines Counterfeits Developing World Donations Economic footprint Efficacy Ethics; Code; Business integrity; Compliance Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Geneva Pharma Forum IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem IP IVS Latin America Latin America Conference Malaria MDGs Medicines Mental and Neurological Disorders Millennium Development Goals NCD NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases NTDs Pandemic Influenza Pandemic preparedness partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention PSI Publications Public Health Quality R&D Regulatory regulatory systems Regulatory System Strengthening Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Vaccine Supply Value of Innovation Videos WHA WHO WIPO Women’s Cancers